Receptor tyrosine kinases (RTKs) and PI3K-Akt-mTOR signaling play essential roles in multiple adverse biological behaviors including tumorigenesis and progression and are associated with poor prognosis and therapeutic resistance for several types of malignancy including cervical cancer [43, 64–66]. This evidence concerns the gene MTOR and cervical carcinoma.